Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 06:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update

Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in...
January 09, 2026 06:00 ET | Source: RadNet, Inc.

RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned...
January 09, 2026 05:00 ET | Source: SANUWAVE Health, Inc.

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Sanuwave Health Reports Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
January 09, 2026 05:00 ET | Source: MoonFox Data

MoonFox Data | Li Auto’s Performance Plunges, BEV Transition Faces Formidable Headwinds

Li Auto (NYSE: LI; HKEX: 2015) Q3 2025: RMB 625M net loss (≈$89.3M), revenue -36% YoY, deliveries -39% YoY—ending 11 profitable quarters.
January 08, 2026 22:49 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
January 08, 2026 19:30 ET | Source: Soren Acquisition Corp.

Soren Acquisition Corp. Announces Closing of $253 Million Initial Public Offering

Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units...
January 08, 2026 18:46 ET | Source: Mesoblast Limited

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of...
January 08, 2026 18:13 ET | Source: Semilux International Ltd.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.

Taipei, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Semilux International Ltd. (the “Company”) received a letter (the “MVLS Deficiency Notice”) from the listing qualifications department staff (the...
January 08, 2026 18:10 ET | Source: Lafayette Digital Acquisition Corp. I

Lafayette Digital Acquisition Corp. I Announces Pricing of $250,000,000 Initial Public Offering

Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Lafayette Digital Acquisition Corp. I (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted...
January 08, 2026 18:00 ET | Source: AnaptysBio, Inc.

Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026 SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage...